Delivery Order SPE2DB20D1050-SPE2DB24FH59B
- Not listed
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide NURTEC ODT 75 MG TABLET 8S. The contract has a potential value of $41,050.40 and a performance period through March 8, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,747.18 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading pharmaceutical sourcing and distribution company. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a period of performance through March 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply NURTEC ODT 75 MG TABLET 8S. The contract has a completion date of February 1, 2024, and a potential value of $14,142.83. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide NURTEC ODT 75 MG TABLET 8S. The total potential value of this order is $1,643.50, with a completion date of February 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which has a potential value of up to $999,999,999.00 and a performance...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,576.66 to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract, which has an ultimate completion date of March 21, 2024, is for the supply of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. This order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S pharmaceutical products. The contract has a potential value of $5,550.66 and a completion date of February 29, 2024. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $17,786.54 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of pharmaceutical product NURTEC ODT 75 MG TABLET 8S. This delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract valued at $7,259.23 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a specialty pharmaceutical product, with a period of performance through March 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a $29,479.81 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564297318 NURTEC ODT 75 MG TABLET 8S. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a ceiling value of $20,965.84 and a performance period through April 8, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp as the...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB24FH59BDelivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide the drug NURTEC ODT 75 MG TABLET 8S. The contract has a ceiling value of $5,733.54 and a performance period through April 2, 2024. This delivery order appears to be part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which has a potential value of up to $999,999,999.00 and runs through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to supply pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this particular delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 4/1/24 |